Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Allergy Therapeutics Plc (AGYTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 0
  • Shares Outstanding, K 0
  • Annual Sales, $ 92,060 K
  • Annual Income, $ -10,150 K
  • 60-Month Beta -0.86
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.25
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/02/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1700 unch
on 02/22/19
0.1700 unch
on 02/22/19
N/A (-9.57%)
since 01/08/19
3-Month
0.1700 unch
on 02/22/19
0.1880 -9.57%
on 01/08/19
-0.0180 (-9.57%)
since 12/09/16

Most Recent Stories

More News
Global Allergy Immunotherapy (AIT) Industry Analysis & Outlook (2019-2023): Dominant Players are ALK-Abello; Stallergenes Greer; Allergy Therapeutics; and Allergopharma - ResearchAndMarkets.com

The "Global Allergy Immunotherapy (AIT) Market: Industry Analysis & Outlook (2019-2023)" report has been added to ResearchAndMarkets.com's offering.

AGYTF : 0.1700 (-9.57%)
Trade AGYTF with:

Key Turning Points

2nd Resistance Point 0.1700
1st Resistance Point 0.1700
Last Price 0.1700
1st Support Level 0.1700
2nd Support Level 0.1700

See More

52-Week High 0.1880
Fibonacci 61.8% 0.1811
Fibonacci 50% 0.1790
Fibonacci 38.2% 0.1769
Last Price 0.1700
52-Week Low 0.1700

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar